Evidence map›Paper›PMID 17021139›Full record

ArticleJournal of clinical pathology2006

Coexpression of an unusual form of the EWS-WT1 fusion transcript and interleukin 2/15 receptor betamRNA in a desmoplastic small round cell tumour.

Y Nakanishi, T Oinuma, M Sano, F Fuchinoue, K Komatsu, T Seki, Y Obana, M Tabata, K Kikuchi, M Shimamura and 2 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of clinical pathology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Y NakanishiDepartment of Pathology, Nihon University School of Medicine, Tokyo, Japan.
T Oinuma
M Sano
F Fuchinoue
K Komatsu
T Seki
Y Obana
M Tabata
K Kikuchi
M Shimamura
K Ohmori
N Nemoto
Nihon University · JPNihon University Itabashi Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe beta chain of the interleukin 2/15 receptor (IL-2/15Rbeta) is induced by the expression of the EWS-WT1. A case of desmoplastic small round cell tumour (DSRCT) expressing only an unusual EWS-WT1 treated by us is reported here.

aimTo characterise an unusual form of EWS-WT1.

methodsFrozen tissue sections of the axillary tumour were examined using a laser-assisted microdissection technique and reverse transcriptase polymerase chain reaction.

resultsThe novel fusion of exon 8 of EWS and the defective exon 10 of WT1 (-KTS) was detected. Although it was an unusual form, the coexpression of the present EWS-WT1, IL-2/15Rbeta and Janus kinase (JAK1) mRNA was detected in the tumour cells. IL-2 and signal transducers and activators of transcription (STAT5) mRNA were detected in both tumour and stromal cells.

conclusionThe induction of the IL-2/15 receptor signalling pathway may contribute to tumorigenesis in DSRCT through a paracrine or an autocrine system, even though the EWS-WT1 was an unusual form.

Indexed as

AdultBase SequenceCarcinoma, Small CellFatal OutcomeHumansInterleukin-2 Receptor beta SubunitLung NeoplasmsMaleMolecular Sequence DataNeoplasm ProteinsOncogene Proteins, FusionReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, NeoplasmEWS1-WT1 fusion protein, humanInterleukin-2 Receptor beta SubunitNeoplasm ProteinsOncogene Proteins, FusionRNA, MessengerRNA, Neoplasm

Identifiers

PMID17021139
PMCPMC1861750
OpenAlexW2004610438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.